1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Oligoprogression: new trials by email Literature Review of Oligoprogression trials Research Report on Oligoprogression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study Osimertinib, Radiotherapy - NSCLC, EGFR Positive Non-small Cell Lung Cancer | Phase 2 | Active not recruiting | AIO-Studien-gGmbH | 42 | 2022-01-20 | 2026-01-14 |
Radiotherapy (1) · osimertinib (1)
Germany (1)